Cargando…
Neurotoxicity after hematopoietic stem cell transplant in multiple sclerosis
OBJECTIVE: Accelerated brain volume loss has been noted following immunoablative autologous hematopoietic stem cell transplantation (IAHSCT) for multiple sclerosis. As with other MS treatments, this is often interpreted as ‘pseudoatrophy’, related to reduced inflammation. Treatment‐related neurotoxi...
Autores principales: | Thebault, Simon, Lee, Hyunwoo, Bose, Gauruv, Tessier, Daniel, Abdoli, Mohammad, Bowman, Marjorie, Berard, Jason, Walker, Lisa, Rush, Carolina A., MacLean, Heather, Booth, Ronald A., Narayanan, Sridar, Arnold, Douglas L., Tabard‐Cossa, Vincent, Atkins, Harold L., Bar‐Or, Amit, Freedman, Mark S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261754/ https://www.ncbi.nlm.nih.gov/pubmed/32304358 http://dx.doi.org/10.1002/acn3.51045 |
Ejemplares similares
-
High serum neurofilament light chain normalizes after hematopoietic stem cell transplantation for MS
por: Thebault, Simon, et al.
Publicado: (2019) -
Serum neurofilament light chain predicts long term clinical outcomes in multiple sclerosis
por: Thebault, Simon, et al.
Publicado: (2020) -
Serum neurofilament light in MS: The first true blood-based
biomarker?
por: Thebault, Simon, et al.
Publicado: (2021) -
Serum Neurofilament Light Chain Measurement in MS: Hurdles to Clinical Translation
por: Thebault, Simon, et al.
Publicado: (2021) -
Nanopore Fabrication by Controlled Dielectric Breakdown
por: Kwok, Harold, et al.
Publicado: (2014)